Aurobindo Pharma schedules earnings call for May 22, 2026, to discuss Q4 and FY26 audited results.
Call scheduled for 8:30 AM IST with pre-registration required via Zoom webinar link provided.
Earnings presentation will be available on company website post results announcement.
Disclosure made pursuant to SEBI Listing Regulations Regulation 30(2) requirements.